GPT Healthcare Share Price Today (GPTHEALTH)
TODAY IN ONE LINE
GPTHEALTH slipped 0.8% on light volume, in line with Nifty's 0.1% move.
With a market cap of ₹1,252.48 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
GPT Healthcare flags
Key strengths and potential risks.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 13.7% YoY
- ●High Capital EfficiencyROCE of 23.6% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 28.5%
- ●Healthy Operating MarginsOPM is structurally strong at 21.9%
- ●High Promoter HoldingPromoters hold 65.6% skin-in-the-game
- ●Steady Dividend YieldReliable 1.58% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●FII SellingFII holding decreased by 1.76% QoQ
What changed recently?
Recent events, corporate actions, and announcements.
GPT Healthcare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for GPT Healthcare Limited, framed against the sector median so the premium or discount is obvious at a glance.
Valuation
Profitability
Growth
Financial Health
GPT Healthcare Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for GPT Healthcare Limited — derived from the live tape, not yesterday's close.
GPT Healthcare Limited last traded at ₹152.21 with an intraday range of ₹151.05–₹157.43 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹152.21| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 168.84 | +16.63 | +10.92% |
| R3 | 162.46 | +10.25 | +6.73% |
| R2 | 159.94 | +7.73 | +5.08% |
| R1 | 156.08 | +3.87 | +2.54% |
| PIVOT | 153.56 | 1.35 | 0.89% |
| CURRENT | 152.21 | — | — |
| S1 | 149.70 | -2.51 | -1.65% |
| S2 | 147.18 | -5.03 | -3.30% |
| S3 | 143.32 | -8.89 | -5.84% |
| S4 | 136.94 | -15.27 | -10.03% |
GPTHEALTH is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹153.9–₹157.43
Trading Below opening range, showing Bearishness
GPT Healthcare Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for GPT Healthcare Limited, switchable between annual and quarterly views, consolidated or standalone.
GPT Healthcare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,252.48 Cr. and reported EPS of ₹5.15.
GPT Healthcare segment analysis: revenue and profit mix.
Disclosed business segments at GPT Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
GPT Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for GPT Healthcare Limited.
Our AI distills the core fundamental drivers supporting GPT Healthcare Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
GPT Healthcare Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROCE 23.60% significantly exceeds peer median 15.80%, demonstrating superior capital efficiency.
ROE 28.50% with stable promoter holding 65.57% aligns management incentives with shareholders.
Operating margin 12.08% TTM supports healthy profitability amid competitive healthcare landscape.
Low debt-to-equity ratio 0.0060 provides substantial financial flexibility for growth investments.
TTM EPS grew 13.70% YoY, demonstrating underlying earnings momentum despite recent quarterly softness.
Key Risks.
Latest quarterly EPS declined 12.60% YoY, signaling operational headwinds in recent period.
Net profit fell from ₹12.89 Cr to ₹10.60 Cr sequentially, indicating profit margin compression.
FII holdings eased from 6.68% to 3.20%, signals foreign investor caution on stock.
DII holdings fell from 11.61% to 6.45% QoQ, reduced domestic institutional confidence.
High capex requirements ₹261.62 Cr in latest quarter strain free cash flow generation.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 24%. The operating engine is no longer compounding capital efficiently.
Income thesis breaks if the dividend is cut or yield falls below 0.79%.
GPT Healthcare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GPT Healthcare Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
GPT Healthcare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for GPT Healthcare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
GPT Healthcare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for GPT Healthcare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in GPT Healthcare Limited stood at 52.9% of traded volume, against a 20-day average of 57.0%.
GPT Healthcare announcements: results, concalls, ratings, M&A.
Filings GPT Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
GPT Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 71 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
GPT Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Copy of Newspaper Publication
GPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
General Updates
GPT Healthcare Limited has informed the Exchange about General Updates
Shareholders meeting
GPT Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 06, 2026
Copy of Newspaper Publication
GPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
GPT Healthcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue GPT Healthcare has declared, sequenced by announce and record date.
GPT Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About GPT Healthcare Limited: business, sector, key facts.
What GPT Healthcare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
GPT Healthcare Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: GPTHEALTH, BSE: 544131.
GPTHEALTH, operating under the ILS Hospitals brand, is a significant healthcare provider in India. Its core business centers around a network of multispecialty hospitals offering a comprehensive range of medical services. This expansive portfolio allows them to cater to a wide patient demographic and a broad spectrum of health needs.
The company's medical services are extensive, encompassing a wide array of specialties. These include internal medicine and diabetology for managing chronic conditions; nephrology, with a focus on advanced procedures like renal transplants; surgical expertise covering laparoscopic, general, and specialized areas such as bariatric and metabolic surgery; women's health services encompassing gynecology and obstetrics; and critical care services within their emergency departments.
Further specializations within GPTHEALTH's hospital network include gastroenterology for digestive health; orthopedics and joint replacement surgery; interventional cardiology for heart-related procedures; neurosciences for neurological conditions; pediatric and neonatal care; and urology. The incorporation of robotic procedures signifies a commitment to utilizing advanced technology for improved precision and minimally invasive surgical options.
Beyond its hospital network, GPTHEALTH extends its reach through ancillary services. These include the operation of clinics and pharmacies, providing convenient access to primary care and medication. The company also participates in academic endeavors and provides diagnostic services, enhancing its comprehensive approach to patient care. An unusual aspect of their operations involves the sale of power, suggesting a possible internal power generation capability supporting hospital operations or a separate revenue stream.
Established in 1989 and headquartered in Kolkata, India, GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd. Its long history and diversified services position it as a substantial player in the Indian healthcare landscape, indicating a commitment to long-term growth and development within the sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about GPT Healthcare Limited (GPTHEALTH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of GPT Healthcare Limited (GPTHEALTH)?
The current share price of GPT Healthcare Limited (GPTHEALTH) is ₹152.21. Today, the stock has declined by ₹1.89 (1.23%), trading in a range of ₹151.05 to ₹157.43. The stock opened at ₹154.1 with a trading volume of 50,100 shares.
02Is GPT Healthcare Limited stock a good investment for long-term?
GPT Healthcare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,252.48 crores, P/E ratio of 0.00, ROE of 28.50%, and ROCE of 23.60%. The dividend yield stands at 1.58%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of GPT Healthcare Limited stock?
The 52-week high price of GPT Healthcare Limited (GPTHEALTH) is ₹185, while the 52-week low is ₹115. Currently trading at ₹152.21, the stock is 53.2% away from its 52-week low and 17.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy GPT Healthcare Limited stock at the current price?
Whether to buy GPT Healthcare Limited stock at ₹152.21 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 0.00. Today's performance shows a loss of 1.23%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of GPT Healthcare Limited and when is the next dividend?
GPT Healthcare Limited offers a dividend yield of 1.58%, which means for every ₹100 invested at the current price of ₹152.21, you can expect to receive approximately ₹1.58 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of GPT Healthcare Limited?
GPT Healthcare Limited's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 0.00, ROE: 28.50%, ROCE: 23.60%, Dividend Yield: 1.58%, EPS: ₹5.15, Book Value: ₹32.93, and Debt-to-Equity: 0.01. The company's market cap stands at ₹1,252.48 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is GPT Healthcare Limited stock performing today in the market?
GPT Healthcare Limited stock opened at ₹154.1 and is currently trading at ₹152.21, showing a decline of ₹1.89 (1.23%). The intraday high is ₹157.43 and low is ₹151.05. The trading volume stands at 50,100 shares, indicating moderate market participation today.
08What is the P/E ratio of GPT Healthcare Limited and what does it indicate?
GPT Healthcare Limited has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹5.15, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about GPT Healthcare Limited (GPTHEALTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.